Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

Researchers have discovered a method to induce chirality in non-chiral materials using terahertz light. This groundbreaking ...

Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...

Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of heart failure with few treatment options, in another big win for the GLP-1 ...

Insights into the structures could lead to improved treatment strategies for transthyretin amyloidosis, a progressive, fatal disease in men.

Thioxanthones are fascinating organic compounds that have found their way into many industrial and everyday applications. In the printing industry, for example, they help inks dry faster when exposed ...

Eli Lilly's dual GLP-1/GIP agonist tirzepatide has been shown to reduce the risk of worsening disease in people with heart failure and obesity in a phase 3 trial, the first to show a benefit on ...

Researchers are hopeful that drugs currently under development could better access those deeper brain structures. Finally, a few studies in mice have found that the medications can reduce the ...

Structures of ubiquitin–UBD complexes have ... In these processes, ubiquitin acts as a signalling component that can trigger molecular events in cells. It does this by operating as a reversible ...

Often known as the central science, it is a creative discipline chiefly concerned with atomic and molecular structure and its change, for instance through chemical reactions. Mixed conductors ...

They found a specific ... New Insights Into the Biology and Risk Factors of Childhood Obesity Jan. 15, 2025 — A cutting-edge molecular approach provides a detailed picture of the biological ...